GlucoTrack, Inc. (GCTK)
3.05
+0.12
(+4.10%)
USD |
NASDAQ |
Sep 09, 10:56
GlucoTrack Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2019 | 82.04% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | -179.1% |
| March 31, 2018 | 42.91% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2017 | 0.00% |
| December 31, 2016 | 86.41% |
| September 30, 2016 | -23.89% |
| June 30, 2016 | 95.76% |
| March 31, 2016 | 86.87% |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | 85.88% |
| March 31, 2015 | 88.52% |
| December 31, 2014 | 73.54% |
| September 30, 2014 | 65.20% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Nuwellis, Inc. | 76.08% |
| Abbott Laboratories | 52.64% |
| DexCom, Inc. | 63.44% |
| Insulet Corp. | 72.56% |
| AngioDynamics, Inc. | 50.87% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -808.1% |
| Return on Assets | -247.7% |
| Return on Invested Capital | -355.6% |
| Return on Net Operating Assets | -10.72K% |